Amanote Research
Register
Sign In
Correction: Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma Through Induction of OCT4/NANOG Expression
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-16-2538
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
December 15, 2016
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Increased Expression of Protease-Activated Receptors 2 Indicates Poor Prognosis in HBV Related Hepatocellular Carcinoma
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases
Co-Expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
Scientific Reports
Multidisciplinary
Upregulation of Circulating PD-L1/PD-1 Is Associated With Poor Post-Cryoablation Prognosis in Patients With HBV-Related Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis
Oncology Letters
Cancer Research
Oncology
Co-Expression of LASS2 and TGF-β1 Predicts Poor Prognosis in Hepatocellular Carcinoma
Scientific Reports
Multidisciplinary
HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis After Curative Resection
Journal of Oncology
Oncology
High Expression of Thymosin Beta 10 Predicts Poor Prognosis for Hepatocellular Carcinoma After Hepatectomy
World Journal of Surgical Oncology
Surgery
Oncology
CELSR3 mRNA Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Over-Expression of Nanog Predicts Tumor Progression and Poor Prognosis in Colorectal Cancer
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
